Medunik USA expands Siklos® (hydroxyurea) coverage under Medicaid Programs to 37 states

PRINCETON, N.J., July 22, 2025 /PRNewswire/ - Medunik USA, a specialty pharmaceutical company dedicated to providing rare disease patients with access to orphan drugs and part of Duchesnay Pharmaceutical Group (DPG), winner of the 2024 Life Sciences Innovation Award by ADRIQ, is pleased...

Read More